R&D spending bounces back due to sales strength
Company raised more than $250 million
Enzo Biochem post gains, while Fluidigm declines
Latest sales, operating income and net profit figures for analytical and life science instrument and laboratory product companies
Stepped up investments hurt productivity gains
Company announcements, product introductions and orders/sales of note
Latest sales, operating income and net profit figures for analytical and life science instrument and laboratory product companies
Danaher, Fluidigm, Hitachi High-Technologies, Merck and Pacific Biosciences
Company’s Analyst Day showcases its priorities
IBO Indexes push forward despite political uncertainties
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
